Ad-hoc | 4 May 2011 06:52
Fresenius Medical Care AG & Co. KGaA / Key word(s): Quarter Results/Change in Forecast
04.05.2011 06:52
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Fresenius Medical Care Reports First Quarter 2011 Results and Raises
Outlook for 2011
Net revenue of Fresenius Medical Care AG & Co. KGaA increased by 5% to
$3,036 million (+5% at constant currency) in the first quarter of 2011.
Operating income (EBIT) increased by 5% to $445 million. Net income for the
first quarter of 2011 was $221 million, an increase of 5%.
Based on the strong financial results in the first quarter of 2011 and the
elimination of the so-called 'transition adjustment' imposed on dialysis
facilities as part of the new Medicare end-stage renal disease prospective
payment system in the United States, the company raises its outlook for the
full year 2011.
The company now expects to achieve revenue of more than $13 billion.
Previously, the company expected revenue to grow to between $12.8 billion
and $13.0 billion.
Net income attributable to Fresenius Medical Care AG & Co. KGaA is now
expected to be between $1.070 billion to $1.090 billion in 2011.
Previously, the company expected net income to be between $1.035 billion
and $1.055 billion.
For 2011, the company still expects to spend around 5% of revenue on
capital expenditures and approximately $1.2 billion on acquisitions. The
debt/EBITDA ratio is expected to be below or equal to 2.8 by the end of
2011, likewise unchanged from the previous guidance.
Fresenius Medical Care AG & Co. KGaA,
represented by Fresenius Medical Care Management AG,
Board of Management,
Bad Homburg v.d.H., May 4, 2011
04.05.2011 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Deutschland
Phone: +49 (0) 6172- 609 2525
Fax: +49 (0) 6172- 609 2301
E-mail: ir@fmc-ag.com
Internet: www.fmc-ag.de
ISIN: DE0005785802, DE0005785836,
WKN: 578580, 578583
Indices: DAX
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart;
Terminbörse EUREX; NYSE
End of Announcement DGAP News-Service
---------------------------------------------------------------------------